Approved Indications:
Clinically Accepted Off-Label Uses:
Formulation and Route:
Adults and Children ≥ 2 years:
Pediatrics (<2 years):
Elderly:
Special Populations:
Administration Notes:
Bepotastine besilate is a selective histamine H1 receptor antagonist with additional mast cell-stabilizing properties. By blocking H1 receptors on conjunctival and ocular tissue cells, it prevents histamine-induced itching, vasodilation, and increased vascular permeability. Its mast cell stabilization inhibits release of inflammatory mediators, reducing ocular redness, swelling, and itching associated with allergic conjunctivitis.
Common:
Less Common:
Rare / Serious: